Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis

Treatment of multidrug-resistant tuberculosis (MDR-TB) is challenging because of the high toxicity of second-line drugs and the longer treatment duration required compared with drug-susceptible TB. The efficacy of treatment for MDR-TB is poorer than that for drug-susceptible TB. The selection of dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Tae Sun, Jo, Kyung-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902820/
https://www.ncbi.nlm.nih.gov/pubmed/24475350
http://dx.doi.org/10.3947/ic.2013.45.4.367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902820/
https://www.ncbi.nlm.nih.gov/pubmed/24475350
http://dx.doi.org/10.3947/ic.2013.45.4.367

Ejemplares similares